Yuichi Shoburu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuichi Shoburu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Aikou Okamoto
Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan
3 shared publications - Hirokuni Takano
Department of Obstetrics and Gynecology, The Jikei University Kashiwa Hospital, Chiba, Japan
3 shared publications - Kyosuke Yamada
Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan
3 shared publications - Motoaki Saito
Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan
3 shared publications - Eitaro Suzuki
Department of Obstetrics and Gynecology, The Jikei University Katsushika Medical Center, Tokyo, Japan
2 shared publications - Masataka Takenaka
Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 37 (3)
Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients
Yanagida S, et al. J Gynecol Oncol. 2025 Oct;37:e44. https://doi.org/10.3802/jgo.2026.37.e44
- 1 January 2026
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 37 (3)
Open AccessMolecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients
Yanagida S, et al. J Gynecol Oncol. 2025 Oct;37:e44. https://doi.org/10.3802/jgo.2026.37.e44
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 35 (6)
A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer
Komazaki H, et al. J Gynecol Oncol. 2024 Mar;35:e76. https://doi.org/10.3802/jgo.2024.35.e76
- 1 January 2024
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 35 (6)
Open AccessA retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer
Komazaki H, et al. J Gynecol Oncol. 2024 Mar;35:e76. https://doi.org/10.3802/jgo.2024.35.e76
- Open Access
- 7 June 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (5) , e62
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data
Odajima S, et al. J Gynecol Oncol. 2022 Jun;33:e62. https://doi.org/10.3802/jgo.2022.33.e62
- 7 June 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (5) , e62
Open AccessEfficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data
Odajima S, et al. J Gynecol Oncol. 2022 Jun;33:e62. https://doi.org/10.3802/jgo.2022.33.e62